Welcome to Seeking Alpha's Wall Street breakfast, where we cover the top news for investors every morning.

Good morning, today is Friday, November 10th.

I'm Julie Morgan.

DBV Technologies reports positive results in a peanut allergy study.

Meta is back in China 14 years after Facebook was banned, and Black Rock is looking to create an Ethereum EDF.

DBV Technologies reported positive two-year data from an ongoing phase 3 study extension for its peanut allergy treatment

Viaskin peanut and toddlers aged one to three years old.

The company said that after 24 months of therapy, 56% of participants

were able to consume a cumulative dose of 12 to 14 peanut kernels

without meeting the predefined stopping criteria,

with 81.3% able to reach an eliciting dose of

three to four peanut kernels. It noted that prior to treatment the toddler's

eliciting dose range from a fraction of a kernel to roughly one kernel.

No treatment-related anaphylactic or treatment-related serious adverse events were reported

during the second year of treatment.

The company plans to highlight the data during a presentation at the American College of

Allergy, Asthma, and Immunology annual meeting on November 11th.

Pre-market DBT is up 3.8%.

Meta platforms is inked a preliminary deal with 10 cent

to sell a lower-price version of its virtual reality had set in China.

This is happening 14 years after Facebook was banned in the country.

The Wall Street Journal reported citing people familiar with the matter that the deal would make Tencent the exclusive seller of the Quest headset in China.

...